Insider · CIK 0001189022
Robert N Wilson
Files at CALC (CalciMedica, Inc.). First filing Nov 1, 2024, latest Jul 18, 2025.
In brief
Robert N Wilson files SEC Form 4 as director at CALC (CalciMedica, Inc.). Since Nov 1, 2024, Robert N Wilson has reported 2 open-market buys worth $213k and 0 open-market sells worth $0, the latest filed on Jul 18, 2025.
A track record needs three past buys with six months of prices behind them; Robert N Wilson has 1, so none is measured yet.
The newest scored trade: bought $13k of CALC on Jul 18, 2025, filed Jul 18, 2025, scored 38 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CALC: CalciMedica, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | CalciMedica, Inc. | $13k 4,500 shares | +1% | +110% from low-40% from high | |
| 45Moderate | CalciMedica, Inc. | $200k 53,333 shares | +15% | - |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | CALC CalciMedica, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +20,000 | $0.00 | $0 | 20,000 | 8 d ago |
| Aug 19, 2026 | CALC CalciMedica, Inc. | AGrant or award Warrantderivative | +1,182,621 | $0.00 | $0 | 1,182,621 | Aug 21, 2026 |
| Aug 19, 2026 | CALC CalciMedica, Inc. | AGrant or award Warrantderivative | +1,182,621 | $0.00 | $0 | 1,182,621 | Aug 21, 2026 |
| Aug 19, 2026 | CALC CalciMedica, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Aug 21, 2026 |
| Jun 25, 2026 | CALC CalciMedica, Inc. | AGrant or award Common Stock | +1,182,621 | $0.80 | $950k | 1,604,650 | Jun 29, 2026 |
| Jul 18, 2025 | CALC CalciMedica, Inc. | POpen-market purchase Common Stock | +4,500 | $2.87 | $13k | 422,029 | Jul 18, 2025 |
| Jun 24, 2025 | CALC CalciMedica, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Jun 26, 2025 |
| Jun 24, 2025 | CALC CalciMedica, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +12,031 | $0.00 | $0 | 12,031 | Jun 26, 2025 |
| Jun 24, 2025 | CALC CalciMedica, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +36,562 | $0.00 | $0 | 36,562 | Jun 26, 2025 |
| Jun 24, 2025 | CALC CalciMedica, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Jun 26, 2025 |
| Nov 1, 2024 | CALC CalciMedica, Inc. | POpen-market purchase Common Stock | +53,333 | $3.75 | $200k | 417,529 | Nov 1, 2024 |
Questions about Robert N Wilson
Answered from the filings on this page, as of the latest one.
Is Robert N Wilson buying or selling?
Not in the last 12 months. Robert N Wilson's latest open-market trade on SEC Form 4 was bought $13k of CALC on Jul 18, 2025.
How did Robert N Wilson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert N Wilson has 1.
Where does Robert N Wilson file Form 4?
Robert N Wilson has filed Form 4 at CALC (CalciMedica, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.